Pay in 4 interest-free payments of $5.65 Learn more
Ships within 48 hours · Estimated delivery Nov 3 - Nov 8
LY3437943 (Retatrutide): discovery to clinical proof of concept (triple GLP-1/GIP/glucagon agonist, preclinical mechanism) Nature Reviews Endocrinology (2024) Multi-receptor agonists for metabolic disease (mechanism of GLP-1/GIP/glucagon co-activation) Diabetes Care (2024) Incretin-based therapies: GLP-1, GIP, and glucagon receptor pharmacology (metabolic pathways, energy expenditure) NEJM (2023) Supplementary Material Jastreboff et al
Patient has a BMI (body mass index) of 30 or higher, or
J Obes Metab Syndr 2021;30:3205.ArticlePubMedPMC 99
For multi-dose pens, removing visible larger air bubbles helps ensure accurate dosing, though small bubbles are harmless
When you eat less food, it becomes easy to fall short on protein without realizing it
US$ 21.88
US$ 27.30
US$ 27.59
US$ 28.55
